An article on support from an FDA panel to raise the approval bar for certain cancer drugs, Andy Chen, M.D., Ph.D., says demanding randomized trials could slow drug development.

At the first in-person meeting since the start of the pandemic, the OHSU board of directors receive updates on: OHSU's financial status, work to eliminate inequitable treatment, discrimination, harassment and bullying, the strategic plan and the OHSU Knight Cancer Institute.

OHSU's Nurse-Midwifery program is ranked second among the best nurse midwifery schools.

Tyler Van Brunt describes how OHSU Knight Cancer Institute nurses “flattened midday peaks and helped nurses end shifts on time.”

Susan Bakewell-Sachs, Ph.D., R.N., FAAN, says the OHSU School of Nursing and its students benefit from federal education funding that prohibits discrimination, during an online discussion with U.S. Rep. Suzanne Bonamici regarding nursing education.

The personal opinions of an OHSU medical assistant via Twitter draw attention. OHSU's response to requests for comment: "We can confirm that Danielle Salinas is an employee at OHSU. Her views are her own; she does not speak on behalf of OHSU. OHSU will not comment on confidential personnel matters."

Peter Graven, Ph.D., says relatively high vaccination rates coupled with people’s natural immunity to the virus will likely keep cases from skyrocketing again.

Peter Graven, Ph.D., says relatively high vaccination rates coupled with people’s natural immunity to the virus will likely keep cases from skyrocketing again.

In response to a claim that OHSU's 30-30-30 plan to address the state’s urgent health care workforce crisis by increasing the size and diversity of OHSU’s health professional education programs is unconstitutional, OHSU shared a statement that reads, in part: “OHSU 30-30-30 does not violate the Fourteenth Amendment. OHSU will continue to engage in an individualized, holistic review of all applicants’ merit while prioritizing the addition of high-quality clinicians from diverse backgrounds to the state’s hospitals and clinics over the next decade, and the prioritizing educational benefits of a more diverse student body for all OHSU students."

Ov Slayden, Ph.D., and Oleh Taratula, Ph.D., develop a new nanotechnology approach to locate and remove endometriosis lesions.